Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomerica (BMRA) Accumulated Expenses (2016 - 2025)

Historic Accumulated Expenses for Biomerica (BMRA) over the last 15 years, with Q4 2025 value amounting to $545000.0.

  • Biomerica's Accumulated Expenses fell 931.78% to $545000.0 in Q4 2025 from the same period last year, while for Nov 2025 it was $545000.0, marking a year-over-year decrease of 931.78%. This contributed to the annual value of $655000.0 for FY2025, which is 0.0% changed from last year.
  • As of Q4 2025, Biomerica's Accumulated Expenses stood at $545000.0, which was down 931.78% from $591000.0 recorded in Q3 2025.
  • Biomerica's Accumulated Expenses' 5-year high stood at $702000.0 during Q1 2024, with a 5-year trough of $366936.0 in Q1 2021.
  • For the 5-year period, Biomerica's Accumulated Expenses averaged around $598337.4, with its median value being $627500.0 (2024).
  • As far as peak fluctuations go, Biomerica's Accumulated Expenses soared by 7201.96% in 2021, and later plummeted by 1282.05% in 2025.
  • Quarter analysis of 5 years shows Biomerica's Accumulated Expenses stood at $674327.0 in 2021, then grew by 3.39% to $697179.0 in 2022, then fell by 4.19% to $668000.0 in 2023, then dropped by 10.03% to $601000.0 in 2024, then fell by 9.32% to $545000.0 in 2025.
  • Its Accumulated Expenses stands at $545000.0 for Q4 2025, versus $591000.0 for Q3 2025 and $655000.0 for Q2 2025.